Swiss medtech company opens its first flagship store in Zurich
Bloom Diagnostics to mark opening by enabling consumers to try smart testing for a range of conditions first-hand
SWITZERLAND: Swiss medtech company Bloom Diagnostics has, today, opened its first-ever flagship store at a busy pedestrian zone in Zurich, Switzerland. The store launch will see consumers avail of free smart-testing, which can help detect a range of serious conditions. Bloom Diagnostics is an innovative medtech company that has developed a smart diagnostic system for a wide range of medical fields, tests range from ferritin levels in the blood to assess anemia and iron deficiency to TSH (Thyroid Stimulating Hormone) or AMH (Anti-Müllerian Hormone) levels and many more in the future.
To kick off the launch, Bloom Diagnostics Co-founder and Chairperson Angelica Kohlmann, MD PhD will deliver a short presentation on the company’s mission on making healthcare more accessible as well as Bloom Diagnostics plans for the next 12 months. The Co-founder and Chief Product Officer, Thomas Kupper will highlight the advantages of the Bloom System and introduce the future product portfolio. The store, which is located on Fortunagasse 11, will allow consumers to test and purchase the Bloom Lab, a smart electronic reader that provides users access to a range of at-home, or self-tests, thereby reducing pressure on GPs and healthcare systems.
The Bloom System currently offers a finger prick ferritin home test kit which provides a quick on-the-spot result in ten minutes and delivers personal insights on ferritin levels directly on users’ smartphones. According to the WHO, anemia is affecting around 30 percent of non-pregnant women worldwide, with approximately half of these cases estimated to be caused by a lack of iron. In addition to this, Johns Hopkins Medicine states that the most common cause of anemia worldwide is iron deficiency. Women who are menstruating, as well as anyone that may be regularly losing blood, such as those suffering from some gastrointestinal diseases, can help detect any irregularities from testing ferritin levels at home. The Bloom System also has a number of additional testing models in the pipeline, including AMH (Anti-Müllerian Hormone) which estimates women’s individual ovarian reserve as an ancillary screen of fertility, TSH (Thyroid Stimulating Hormone) which reflects the thyroid status in the blood and screens for primary hypothyroidism.
Commenting on the launch of Bloom’s first-ever store, Co-founder and Chairperson Angelica Kohlmann said: “Bloom Diagnostics has been developing products to enable patients to take control of their healthcare with at-home self-testing kits and relieving the pressure on healthcare systems since 2018. After the first regulatory approvals, we are delighted to open our first walk-in Bloom Store at a busy pedestrian zone in Zurich. Our mission is to democratize access to high-quality healthcare and focus on individual patients and their healthcare journey, and our new store brings us one step closer to achieving this goal. Furthermore, the COVID-19 pandemic has demonstrated that healthcare systems are under extreme pressure and the Bloom System offers the opportunity to relieve some of that strain by allowing patients to self-test at home and in pharmacies.”
For more on Bloom Diagnostics please see www.bloomdiagnostics.com/
Notes to Editor:
About Bloom Diagnostics
Bloom Diagnostics is an innovative medtech company whose hardware and software can identify a range of medical conditions, using a combination of advanced biotechnology, cloud computing and scientific research. Bloom Diagnostics’ sophisticated system allows consumers to take control of their own health. Through its next-generation technology and personalized data insights, Bloom Diagnostics applies machine learning to improve results and analyze data that may eventually help develop new therapeutics. Founded by Dr. Angelica Kohlmann and Thomas Kupper in 2018, it is headquartered in Zurich and also has offices in Vienna. With a team of 60 employees, Bloom Diagnostics has plans to drive expansion across Europe and the USA. For further information, visit: https://www.bloomdiagnostics.com/
Angelica Kohlmann serves as Chairperson of the non-executive Board of the Company. She holds an MD and doctorate in medicine from Hamburg University (GER). She has been Chairperson of the Advisory Board Peter Drucker Society Europe / Global Peter Drucker Forum, Vienna since 2009 and is a non-executive Board member of private and public companies including Teralytics AG (since 2014) and Lonza Group (since 2018). She is also a serial investor in successful companies, with multiple exits, as the latest of CTRL-labs, which was sold to Facebook in 2019.
For interview requests or media enquiries, please contact:
Senior Account Executive,
M: +353 (0)85 725 0914
O: +353 (0)1 961 0048